GO:0140946 histone H3K4 dimethyltransferase activity

Histone H3 lysine 4 (H3K4) methylation is a central chromatin modification that marks active regulatory regions. GO:0140946, histone H3K4 dimethyltransferase activity, defines the catalytic step that converts unmethylated H3K4 to the dimethylated form H3K4me2 through two successive methyl-transfer reactions using S-adenosyl-L-methionine. This activity is distinct from mono- and trimethylation and is carried out by dedicated histone lysine methyltransferases such as MLL4 (KMT2D). Understanding GO:0140946 is essential because H3K4me2 is a key epigenetic mark at enhancers and promoters, and its deposition is tightly linked to gene activation programs. MLL4 is a well-characterized H3K4 mono- and di-methyltransferase that requires its catalytic activity for enhancer activation during cell differentiation. Importantly, the H3K4 methyltransferase activity of MLL4 is also required for MLL4 protein stability, indicating that the enzymatic function of this protein is coupled to its own regulation. These findings place GO:0140946 at the intersection of chromatin biology, transcriptional control, and developmental gene regulation. For researchers, GO:0140946 provides a precise functional annotation for experiments involving H3K4me2, enhancer biology, and methyltransferase structure-function studies. Because the reaction produces H3K4me2 rather than H3K4me1 or H3K4me3, assays and models must be designed to distinguish these methylation states. This article summarizes the definition, mechanism, key genes, disease relevance, and research methods associated with GO:0140946.

GO:0140946, histone H3K4 dimethyltransferase activity, is a molecular function defined as the catalysis of the reaction in which L-lysyl4-[histone H3] is modified by two molecules of S-adenosyl-L-methionine to produce N6,N6-dimethyl-L-lysyl4-[histone H3], two protons, and two molecules of S-adenosyl-L-homocysteine. In other words, this activity performs the successive addition of two methyl groups to the unmethylated lysine residue at position 4 of histone H3, generating the histone H3K4me2 mark. The term is synonymous with histone H3K4 dimethylase activity, histone H3-K4 dimethylation, histone H3K4 dimethylation, and histone lysine N-dimethyltransferase activity (H3-K4 specific).

GO:0140946 is important because H3K4me2 is a chromatin mark that contributes to active enhancer and promoter states, and the enzymes that generate it are critical for cell differentiation and development. MLL4, a major H3K4 mono- and di-methyltransferase, requires its catalytic activity for enhancer activation during cell differentiation, and this same activity is required for MLL4 protein stability. Thus, GO:0140946 connects enzymatic chromatin modification to transcriptional regulation, protein stability, and developmental gene expression programs.

The following genes and proteins are directly implicated in histone H3K4 dimethyltransferase activity (GO:0140946) or in the deposition and interpretation of its product, H3K4me2, based on the verified literature.

The activity described by GO:0140946 is regulated at multiple levels. MLL4, a principal H3K4 mono- and di-methyltransferase, requires its catalytic H3K4 methyltransferase activity for protein stability, indicating that the enzymatic function itself influences the abundance of the enzyme. In addition, MLL4 is required for enhancer activation during cell differentiation, suggesting that its recruitment to specific enhancers and its activity are developmentally controlled. The presence of H3K4 demethylases such as KDM5 family enzymes further regulates steady-state H3K4me2 levels, although direct evidence for their role in the context of GO:0140946 specifically is beyond the scope of the verified citations provided here.

MLL4 (KMT2D) is an H3K4 mono- and di-methyltransferase required for enhancer activation during cell differentiation. Because GO:0140946 produces H3K4me2, a mark associated with active enhancers, loss of this activity is expected to impair enhancer-dependent gene expression programs. The requirement of MLL4 catalytic activity for protein stability further suggests that disease-associated mutations affecting catalysis could also reduce MLL4 protein levels. These mechanisms link GO:0140946 to developmental gene regulation.

H3K4 methylation is a central epigenetic mark in cancer biology, and enzymes that deposit H3K4me2 are frequently studied in tumor models. MLL4 is a member of the KMT2 family of H3K4 methyltransferases, and its activity is required for enhancer activation during cell differentiation. Dysregulation of H3K4me2 levels could therefore contribute to altered enhancer landscapes in cancer, although the verified citations provided here focus on MLL4 function in differentiation and stability rather than direct cancer statistics.

In vitro methyltransferase assays using recombinant histone H3 or H3 peptides and S-adenosyl-L-methionine can directly measure GO:0140946 activity. These assays detect the transfer of methyl groups to lysine 4 and can distinguish mono-, di-, and tri-methylation states when coupled with methylation-specific antibodies or mass spectrometry. Such assays are essential for confirming that a candidate enzyme, such as MLL4, possesses H3K4 dimethyltransferase activity.

Chromatin immunoprecipitation (ChIP) with antibodies specific for H3K4me2, followed by quantitative PCR or sequencing, measures the genomic distribution of the product of GO:0140946. Because H3K4me2 is associated with active enhancers and promoters, ChIP-seq can reveal whether loss of an H3K4 dimethyltransferase reduces H3K4me2 at specific regulatory elements. This approach is particularly useful in differentiation models where MLL4 is required for enhancer activation.

Because H3K4 methyltransferase activity is required for MLL4 protein stability, western blotting and quantitative proteomics can assess whether mutations that abolish GO:0140946 activity also reduce MLL4 protein levels. Tagged knock-in models or degron systems can further dissect the relationship between catalysis and protein turnover. These methods help distinguish loss of activity from loss of protein.

RNA-seq and enhancer RNA profiling can measure the functional consequences of altering GO:0140946 activity. In cells lacking MLL4 catalytic activity, enhancer activation during differentiation is impaired, which can be detected as changes in enhancer RNA levels and target gene expression. Combining transcriptomics with H3K4me2 ChIP-seq provides a integrated view of how this enzymatic activity shapes gene expression programs.

Researchers studying histone H3K4 dimethyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in H3K4me2 deposition, enhancer activation, or differentiation. EDITGENE provides CRISPR-based cell model services that enable precise manipulation of H3K4 methyltransferase genes such as KMT2D (MLL4), allowing functional dissection of GO:0140946 in relevant cellular contexts.

GO:0140946, histone H3K4 dimethyltransferase activity, defines the enzymatic step that produces H3K4me2, a chromatin mark associated with active enhancers and promoters. MLL4 (KMT2D) is a principal enzyme carrying this activity, and its catalytic function is required for enhancer activation during cell differentiation and for its own protein stability. Understanding this activity is essential for interpreting H3K4 methylation experiments and for designing CRISPR models that dissect catalysis from protein scaffolding. Researchers can leverage knockout, point-mutation, knock-in, and overexpression models to test the causal role of H3K4 dimethyltransferase activity in gene regulation and disease. EDITGENE provides these CRISPR services to accelerate functional studies of GO:0140946 and its associated genes.